Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Bioorganic & Medicinal Chemistry
|
October 2, 2013
New non-symmetrical choline kinase inhibitors
Santiago Schiaffino-Ortega, Luisa Carlota López-Cara, Pablo Ríos-Marco, et al.
Chemical Communications (Cambridge, England)
|
August 2, 2024
Iron homo- and heterobimetallic complexes supported by a symmetrical dinucleating ligand
Pablo Ríos, Matthew S See, Oscar Gonzalez, et al.
European Journal of Medicinal Chemistry
|
February 22, 2012
Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors
Belén Rubio-Ruíz, Ana Conejo-García, Pablo Ríos-Marco, et al.
The Plant Journal : for Cell and Molecular Biology
|
May 12, 2017
ETHQV6.3 is involved in melon climacteric fruit ripening and is encoded by a NAC domain transcription factor
Pablo Ríos, Jason Argyris, Juan Vegas, et al.
Pharmaceutics
|
February 26, 2022
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines
Pablo García-Molina, Alberto Sola-Leyva, Pilar M Luque-Navarro, et al.
Future Medicinal Chemistry
|
April 16, 2015
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1
Francisco Fermín Castro-Navas, Santiago Schiaffino-Ortega, María Paz Carrasco-Jimenez, et al.
Journal of Medicinal Chemistry
|
January 7, 2014
Discovery of a new binding site on human choline kinase α1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives
Belén Rubio-Ruiz, Ainoa Figuerola-Conchas, Javier Ramos-Torrecillas, et al.
Scientific Reports
|
April 1, 2016
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)
Santiago Schiaffino-Ortega, Eleonora Baglioni, Elena Mariotto, et al.
Future Medicinal Chemistry
|
July 26, 2018
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors
Gianluca Rubbini, Ana Begoña Buades-Martín, María Kimatrai-Salvador, et al.
Hemasphere
|
November 13, 2024
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry
David F Moreno, Cristina Jiménez, Fernando Escalante, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Bioorganic & Medicinal Chemistry
|
October 2, 2013
New non-symmetrical choline kinase inhibitors
Santiago Schiaffino-Ortega, Luisa Carlota López-Cara, Pablo Ríos-Marco, et al.
Chemical Communications (Cambridge, England)
|
August 2, 2024
Iron homo- and heterobimetallic complexes supported by a symmetrical dinucleating ligand
Pablo Ríos, Matthew S See, Oscar Gonzalez, et al.
European Journal of Medicinal Chemistry
|
February 22, 2012
Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors
Belén Rubio-Ruíz, Ana Conejo-García, Pablo Ríos-Marco, et al.
The Plant Journal : for Cell and Molecular Biology
|
May 12, 2017
ETHQV6.3 is involved in melon climacteric fruit ripening and is encoded by a NAC domain transcription factor
Pablo Ríos, Jason Argyris, Juan Vegas, et al.
Pharmaceutics
|
February 26, 2022
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines
Pablo García-Molina, Alberto Sola-Leyva, Pilar M Luque-Navarro, et al.
Future Medicinal Chemistry
|
April 16, 2015
New more polar symmetrical bipyridinic compounds: new strategy for the inhibition of choline kinase α1
Francisco Fermín Castro-Navas, Santiago Schiaffino-Ortega, María Paz Carrasco-Jimenez, et al.
Journal of Medicinal Chemistry
|
January 7, 2014
Discovery of a new binding site on human choline kinase α1: design, synthesis, crystallographic studies, and biological evaluation of asymmetrical bispyridinium derivatives
Belén Rubio-Ruiz, Ainoa Figuerola-Conchas, Javier Ramos-Torrecillas, et al.
Scientific Reports
|
April 1, 2016
Design, synthesis, crystallization and biological evaluation of new symmetrical biscationic compounds as selective inhibitors of human Choline Kinase α1 (ChoKα1)
Santiago Schiaffino-Ortega, Eleonora Baglioni, Elena Mariotto, et al.
Future Medicinal Chemistry
|
July 26, 2018
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors
Gianluca Rubbini, Ana Begoña Buades-Martín, María Kimatrai-Salvador, et al.
Hemasphere
|
November 13, 2024
Prognostic risk and survival of asymptomatic IgM monoclonal gammopathy: Results from a Spanish Multicenter Registry
David F Moreno, Cristina Jiménez, Fernando Escalante, et al.
Page
of 7